Information about results of Request for proposal RFP – 027916 – PHARMACOKINETIC STUDY OF INVESTIGATIONAL MEDICINAL PRODUCTS FOR ORAL INHALATION 

Adamed Pharma informs that, pursuant to the provisions of Section VI.1 of the RFP, the procedure conducted in connection with the planned launch of the project entitled “Technological development, clinical demonstration of bioequivalence and implementation of an next generation, three component generic inhaled medicinal product for the maintenance treatment of respiratory diseases: Asthma”, has been cancelled.